Cortellini et al., showed higher BMI was associated with higher rates of trAEs and subsequent treatment discontinuation in a cohort of 1070 patients receiving PD-1/PD-L1 inhibition for multiple primary cancer sites [47]. Here, CD274 is linked to cancer.